Inventor
JONES PHILIP
US135 patents
⚠️ This page may combine multiple inventors who share the name “JONES PHILIP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TEXAS
17 patentsUS10344025B2Jul 9, 2019
GLS1 inhibitors for treating disease
UNIV TEXAS12 citations91
US10280171B2May 7, 2019
Heterocyclic inhibitors of PTPN11
UNIV TEXAS24 citations91
US9809588B2Nov 7, 2017
GLS1 inhibitors for treating disease
UNIV TEXAS15 citations91
US11603365B2Mar 14, 2023
Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide
UNIV TEXAS4 citations85
US11370786B2Jun 28, 2022
GLS1 inhibitors for treating disease
UNIV TEXAS6 citations84
US10899740B2Jan 26, 2021
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
UNIV TEXAS8 citations84
US10150753B2Dec 11, 2018
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
UNIV TEXAS7 citations84
US10766892B2Sep 8, 2020
GLS1 inhibitors for treating disease
UNIV TEXAS9 citations83
US10738043B2Aug 11, 2020
GLS1 inhibitors for treating disease
UNIV TEXAS6 citations83
US10421765B2Sep 24, 2019
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
UNIV TEXAS7 citations82
US10392376B2Aug 27, 2019
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS7 citations82
US9115120B2Aug 25, 2015
Heterocyclic modulators of HIF activity for treatment of disease
UNIV TEXAS9 citations82
US11400108B2Aug 2, 2022
Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
UNIV TEXAS1 citations73
US10933078B2Mar 2, 2021
Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
UNIV TEXAS2 citations73
US10363248B2Jul 30, 2019
Salts of heterocyclic modulators of HIF activity for treatment of disease
UNIV TEXAS2 citations73
US10093664B2Oct 9, 2018
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
UNIV TEXAS4 citations73
US12186324B2Jan 7, 2025
Imidazopiperazine inhibitors of transcription activating proteins
UNIV TEXAS3 citations72
MERCK SHARP & DOHME
5 patentsUS7030128B2Apr 18, 2006
Imidazo-pyrimidine derivatives as ligands for GABA receptors
MERCK SHARP & DOHME11 citations84
US6900215B2May 31, 2005
Imidazo-pyrimidine derivatives as ligands for gaba receptors
MERCK SHARP & DOHME16 citations83
US6730681B2May 4, 2004
Triazolo-pyrimidine derivatives as ligands for gaba receptors
MERCK SHARP & DOHME18 citations83
US7279580B2Oct 9, 2007
Imidazo-pyridine derivatives as ligands for GABA receptors
MERCK SHARP & DOHME15 citations81
US6900209B2May 31, 2005
Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition
MERCK SHARP & DOHME8 citations73
JONES PHILIP
3 patentsUS8071623B2Dec 6, 2011
Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors
JONES PHILIP85 citations96
US8188084B2May 29, 2012
Pyridinone and pyridazinone derivatives as inhibitors of poly (ADP-ribose) polymerase (PARP)
JONES PHILIP24 citations91
US12053916B1Aug 6, 2024
Fishing lure injection molding using additive manufacturing
JONES PHILIP2 citations72
BOARD OF REGENTS UNIV OF TEXAS SYSTEM
3 patentsUS9663504B2May 30, 2017
Salts of heterocyclic modulators of HIF activity for treatment of disease
BOARD OF REGENTS UNIV OF TEXAS SYSTEM6 citations83
US10125128B2Nov 13, 2018
GLS1 inhibitors for treating disease
BOARD OF REGENTS UNIV OF TEXAS SYSTEM13 citations82
US9481692B2Nov 1, 2016
Heterocyclic modulators of HIF activity for treatment of disease
BOARD OF REGENTS UNIV OF TEXAS SYSTEM4 citations81
ANGELETTI P IST RICHERCHE BIO
3 patentsUS7977374B2Jul 12, 2011
Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors
ANGELETTI P IST RICHERCHE BIO8 citations83
US7799825B2Sep 21, 2010
Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors
ANGELETTI P IST RICHERCHE BIO9 citations83
US7834015B2Nov 16, 2010
Pyrrolo[1,2-a] pyrazin-1(2H)-one and pyrrolo[1,2-d][1,2,4]triazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose)polymerase (PARP)
ANGELETTI P IST RICHERCHE BIO20 citations82
ULTRAHAPTICS IP LTD
2 patentsMOTOROLA INC
2 patentsNAVIRE PHARMA INC
2 patentsIBM
2 patentsBARDEN JULIAN ALEXANDER
1 patentBOEING CO
1 patentHILTI AG
1 patentSUNOVION PHARMACEUTICALS INC
1 patentBIOSCEPTRE AUST PTY LTD
1 patentBIOSCEPTRE INT LTD
1 patentLUSCHI CARLO
1 patentCAMPBELL JOHN EMMERSON
1 patentBRANCA DANILA
1 patentINST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT
1 patentPITCRAFT SUMMIT LTD
1 patentShowing the top 50 of 135 patents by PatentIndex Score.